Lexicon Pharmaceuticals Inc (LXRX)

Dec 10, 2025

Lexicon Pharmaceuticals to advance obesity treatment with new ACSL5 inhibitor data - Traders Union

Dec 10, 2025

Dec 10, 2025

Novo Nordisk (NVO) Collaborates with Lexicon on Obesity Treatmen - GuruFocus

Dec 10, 2025

Dec 10, 2025

Lexicon Pharmaceuticals Publishes Preclinical Data Supporting ACSL5 as Target for Obesity Treatment - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

Lexicon Pharmaceuticals (Nasdaq: LXRX) publishes ACSL5 obesity data supporting LX9851 - Stock Titan

Dec 10, 2025

Dec 07, 2025

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Dec 07, 2025

Dec 05, 2025

Clinical data on effect of sotagliflozin on adipose distribution in non-diabetic patients - marketscreener.com

Dec 05, 2025

Dec 05, 2025

Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum - The Manila Times

Dec 05, 2025

Dec 05, 2025

Clinical Data On Effect Of Sotagliflozin On Adipose Distribution In Non-Diabetic Patients - TradingView

Dec 05, 2025

Dec 05, 2025

Lexicon Pharmaceuticals to Present Clinical Data on Sotagliflozin at CVCT 2025 Conference - Quiver Quantitative

Dec 05, 2025

Dec 05, 2025

Lexicon Pharmaceuticals, Inc. (LXRX) Makes Progress in Product Pipeline Development - MSN

Dec 05, 2025

Dec 05, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for ETFs2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser

Dec 05, 2025

Dec 04, 2025

Year in Review: Local co. striking deal worth up to $1B with Ozempic maker was a Deal of the Week - The Business Journals

Dec 04, 2025

Dec 03, 2025

Carcinoid Syndrome Market to Expand Significantly by 2034, - openPR.com

Dec 03, 2025

Dec 03, 2025

Lexicon Pharmaceuticals Has Multiple Paths To Upside, But Formidable Hurdles As Well - Seeking Alpha

Dec 03, 2025

Dec 03, 2025

Piper Sandler Healthcare Conference - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Lexicon Pharmaceuticals (LXRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 03, 2025

Dec 02, 2025

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Dec 02, 2025

Nov 29, 2025

Will Lexicon Pharmaceuticals Inc. stock deliver long term returns2025 Market Overview & Fast Entry High Yield Stock Tips - moha.gov.vn

Nov 29, 2025

Nov 25, 2025

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences - The Manila Times

Nov 25, 2025

Nov 25, 2025

Lexicon Pharma (Nasdaq: LXRX) in Piper Sandler 37th and Evercore 8th investor events - Stock Titan

Nov 25, 2025

Nov 25, 2025

Would You Still Hold Lexicon Pharmaceuticals Stock If It Fell 30%? - Trefis

Nov 25, 2025

Nov 23, 2025

10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey

Nov 23, 2025

Nov 21, 2025

Why Lexicon Pharmaceuticals Inc. stock is considered a top pick2025 Stock Rankings & Daily Market Momentum Tracking - newser.com

Nov 21, 2025

Nov 21, 2025

Can Lexicon Pharmaceuticals Inc. stock deliver consistent earnings growthWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Will Lexicon Pharmaceuticals Inc. stock split attract more investorsBear Alert & Daily Price Action Insights - newser.com

Nov 20, 2025

Nov 20, 2025

Can Lexicon Pharmaceuticals Inc. stock resist market sell offs2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com

Nov 20, 2025

Nov 20, 2025

Can Lexicon Pharmaceuticals Inc. stock surprise with earnings upsideQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

Nov 20, 2025

Nov 19, 2025

Transcript : Lexicon Pharmaceuticals, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 05 - MarketScreener

Nov 19, 2025

Nov 19, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFs2025 Earnings Surprises & Verified Technical Trade Signals - newser.com

Nov 19, 2025

Nov 19, 2025

How to manage a losing position in Lexicon Pharmaceuticals Inc.Analyst Upgrade & Verified Entry Point Signals - newser.com

Nov 19, 2025

Nov 18, 2025

Lexicon Pharmaceuticals at Jefferies London: Strategic Pipeline Progress By Investing.com - Investing.com Canada

Nov 18, 2025

Nov 18, 2025

Lexicon Pharmaceuticals at Jefferies London: Strategic Pipeline Progress - Investing.com

Nov 18, 2025

Nov 17, 2025

Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm

Nov 17, 2025

Nov 16, 2025

Published on: 2025-11-16 06:10:48 - newser.com

Nov 16, 2025

Nov 16, 2025

Wall Street Zen Downgrades Lexicon Pharmaceuticals (NASDAQ:LXRX) to Hold - MarketBeat

Nov 16, 2025

Nov 15, 2025

Lexicon Pharmaceuticals: A Lottery Ticket With 3 Chances To Win (NASDAQ:LXRX) - Seeking Alpha

Nov 15, 2025

Nov 14, 2025

Lexicon Pharmaceuticals backs Type 1 diabetes research ahead of World Diabetes Day - Traders Union

Nov 14, 2025

Nov 14, 2025

What the charts say about Lexicon Pharmaceuticals Inc. todayTake Profit & Real-Time Chart Breakout Alerts - newser.com

Nov 14, 2025

Nov 13, 2025

What MACD signals say about Lexicon Pharmaceuticals Inc.July 2025 Earnings & Fast Moving Stock Watchlists - newser.com

Nov 13, 2025